Website American Diabetes Association (ADA)
The American Diabetes Association (ADA) is inviting nominations for the Pathway to Stop Diabetes initiative, which supports innovative basic, clinical, translational, epidemiological, behavioral, or health services research relevant to any diabetes type, diabetes-related disease state, or diabetes complication. The Association seeks exceptional candidates from a broad range of disciplines, including medicine, biology, chemistry, computing, physics, mathematics and engineering. This call for nominations will prioritize diabetes research, spanning basic science through public health research and implementation science. The ideal applicant will propose innovative research with the ultimate goal of improving the lives of peole at risk with diabetes or living with the disease.
Each institution is allowed a maximum of two nominations: one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research. The nominations can be in one of the two available Pathway award types (please click on the hyperlinks for each program type’s detail):
- Initiator – For researchers in postdoctoral training (up to 7 years from PhD),
- Accelerator – For early-career diabetes investigators (prior to submitting R01/U01 renewal or second R01/U01 regardless of outcome; may hold first R01 or other NIH funding)
Pathway awards provide up to $1.625 million per award in combined salary and project support. Since UCI may submit only two proposals across both categories, interested applicants (or their nominator) are asked to submit a preliminary application to the Office of Research by May 23, 2024 at 11:59pm (via the UCI Review site), with the following information:
- Clearly state if the applicant is pursuing the preclinical or public health track.
- Clearly state if the type of application is in the Initiator or Accelerator category.
- Brief proposal (up to three pages), outlining the applicant’s research strategy as well as his/her capacity for innovation, creativity and collaboration.
- Please reference the ADA Pathway general review criteria, to ensure each component is adequately addressed.
- Nominee’s Bio sketch (no more than two pages).
If necessary, an ad hoc committee will convene to review the preliminary proposals. The selected nominees will be notified in time to develop their full application and meet the ADA nomination deadline of July 17, 2024.
For the complete nomination guidelines, please refer to the ADA Pathway nomination guidelines.
**Please circulate this message where appropriate as not all eligible candidates are receiving this email (e.g. Postdocs are eligible for the “Initiator” awards).**